Phreesia Inc (PHR)
23.74
+1.56
(+7.03%)
USD |
NYSE |
May 15, 14:44
Phreesia Cash from Investing (Quarterly): -8.158M for Jan. 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | -8.158M |
| October 31, 2023 | -15.72M |
| July 31, 2023 | -9.716M |
| April 30, 2023 | -6.079M |
| January 31, 2023 | -6.599M |
| October 31, 2022 | -6.728M |
| July 31, 2022 | -5.852M |
| April 30, 2022 | -7.024M |
| January 31, 2022 | -40.67M |
| October 31, 2021 | -14.50M |
| July 31, 2021 | -3.154M |
| April 30, 2021 | -6.899M |
| Date | Value |
|---|---|
| January 31, 2021 | -13.98M |
| October 31, 2020 | -3.707M |
| July 31, 2020 | -4.319M |
| April 30, 2020 | -3.077M |
| January 31, 2020 | -3.165M |
| October 31, 2019 | -3.523M |
| July 31, 2019 | -2.907M |
| April 30, 2019 | -2.725M |
| January 31, 2019 | -3.882M |
| October 31, 2018 | -2.281M |
| July 31, 2018 | -2.928M |
| April 30, 2018 | -1.932M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-40.67M
Minimum
Jan 2022
-2.907M
Maximum
Jul 2019
-8.725M
Average
-6.599M
Median
Jan 2023
Cash from Investing (Quarterly) Benchmarks
| Teladoc Health Inc | -35.51M |
| American Shared Hospital Services | -0.097M |
| Novo Integrated Sciences Inc | -- |
| Astrana Health Inc | -71.04M |
| Cryo-Cell International Inc | -0.341M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.078M |
| Cash from Financing (Quarterly) | -4.61M |
| Free Cash Flow | -57.48M |
| Free Cash Flow Per Share (Quarterly) | -0.196 |
| Free Cash Flow to Equity (Quarterly) | -14.09M |
| Free Cash Flow to Firm (Quarterly) | -10.94M |
| Free Cash Flow Yield | -4.44% |